We provide you with 20 years of free, institutional-grade data for VNRX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VNRX. Explore the full financial landscape of VNRX stock.
| Reported Date | CIK | Ticker | Type |
|---|
VolitionRx Limited(NYSE MKT:VNRX) 
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q Vet Cancer Screening Test for veterinary applications. The company also develops blood-based Nu.Q immunoassays to detect...
Website: http://volitionrx.com
Founded: 1998
Full Time Employees: 50
Sector: Healthcare
Industry: Diagnostics & Research
The information provided in this report about VNRX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.